Sage Mountain Advisors’s ProKidney PROK Stock Holding History

Sage Mountain Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-201,113	Closed	-$1.99M	–	637
2022 Q1	$1.99M	Buy	201,113 +127,141	+172%	+$1.25M	0.31%	43
2021 Q4	$733K	Hold	73,972	–	–	0.09%	218
2021 Q3	$725K	Buy	+73,972	New	+$728K	0.1%	193

Other funds holding PROK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Sage Mountain Advisors's PROK Position: Q2 2022 in Review

Sage Mountain Advisors sold out of ProKidney (PROK) in Q2 2022, closing a stake of 201,113 shares — an estimated $1.99M sold.

Sage Mountain Advisors first reported a position in PROK in Q3 2021 and held it in 3 quarters. The position peaked at $1.99M in Q1 2022. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

Sage Mountain Advisors reported no remaining ProKidney position as of Q2 2022 after selling out during the quarter.
Sage Mountain Advisors sold 201,113 ProKidney shares in Q2 2022, an estimated $1.99M.
Sage Mountain Advisors first reported a position in ProKidney in Q3 2021 and held it in 3 quarters.
Sage Mountain Advisors's ProKidney position peaked at $1.99M in Q1 2022.
67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Sage Mountain Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.